Breast Cancer Drug Promising in Phase 3 Trial

WEDNESDAY, Aug. 15, 2018 -- For women with advanced breast cancer who carry the BRCA1 and BRCA2 gene mutations, an experimental drug could improve survival, a new study suggests. The BRCA mutations are linked with a greater risk for aggressive...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news